Page last updated: 2024-08-24

atorvastatin and Granulomatosis with Polyangiitis

atorvastatin has been researched along with Granulomatosis with Polyangiitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bijl, M; de Leeuw, K; Kallenberg, CG; Limburg, PC; Souza, AW; Stegeman, CA; van Timmeren, MM; Westra, J1
Abud-Mendoza, C; Baranda, L; Cruz-Rizo, J; Cuevas-Orta, E; de la Fuente, H; González-Amaro, R1

Trials

1 trial(s) available for atorvastatin and Granulomatosis with Polyangiitis

ArticleYear
Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.
    Lupus, 2003, Volume: 12, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Atorvastatin; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Chloroquine; Dose-Response Relationship, Drug; Granulomatosis with Polyangiitis; Heptanoic Acids; HLA-DR Antigens; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Middle Aged; Proteinuria; Pyrroles; Rheumatic Diseases; Rheumatic Fever; Simvastatin; Treatment Outcome

2003

Other Studies

1 other study(ies) available for atorvastatin and Granulomatosis with Polyangiitis

ArticleYear
Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Atherosclerosis; Atorvastatin; Female; Granulomatosis with Polyangiitis; Heptanoic Acids; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prednisolone; Pyrroles; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility

2014